Dermabond Advanced Topical Adhesive, Mini 12/bx DHVM12 (12/BX) J & J
ETH DHVM12Dermabond Mini Topical Skin Adhesive. 12 per Box
Topical Skin Adhesive -2-octylcyanoacrylate high viscosity formulation for small incisions or lacerations.
| Manufacturer # | DHVM12 |
| Brand | Dermabond® Mini |
| Manufacturer | J & J Healthcare Systems |
| Active Ingredient | 2-Octyl Cyanoacrylate |
| Application | Topical Skin Adhesive |
| Storage Requirements | USP Controlled Room Temperature |
| Tip Type | Dome Applicator Tip |
| Type | High Viscosity |
| UNSPSC Code | 42312005 |
| Volume | 0.36 mL |
Features
- Use to close easily approximated, small incisions or lacerations
- Clinically shown to provide 7-day wound-holding strength in just 3 minutes
- Demonstrates in vitro inhibition of gram-positive bacteria (MRSA and MRSE) and gram-negative bacteria (E coli)
Secure skin closure is an integral step of nearly every surgical procedure. If the closure device does not provide the strength and support required by the skin tissue, the wound edges may separate, providing a potential pathway for bacterial contamination, which can lead to infection, suboptimal cosmesis, and low patient satisfaction.
Strength: When used in addition to sutures DERMABOND ADVANCED Adhesive was shown ex vivo to add 75% more strength to wound closure than sutures alone
•Microbial barrier: DERMABOND ADVANCED Adhesive provides a microbial barrier with 99% protection in vitro for at least 72 hours against organisms commonly responsible for surgical site infections (SSIs)
•Inhibition of bacteria: DERMABOND ADVANCED Adhesive demonstrated in vitro inhibition of gram-positive bacteria (MRSA & MRSE) and gram-negative bacteria (E. coliDERMABOND ADVANCED Adhesive can add strength and protection to an incision.•Strength: When used in addition to sutures, DERMABOND ADVANCED Adhesive was shown ex vivo to add 75% more strength to wound closure than sutures alone1•Microbial barrier: DERMABOND ADVANCED Adhesive provides a microbial barrier with 99% protection in vitro for at least 72 hours against organisms commonly responsible for surgical site infections (SSIs)117,192,*•Inhibition of bacteria: DERMABOND ADVANCED Adhesive demonstrated in vitro inhibition of gram-positive bacteria (MRSA & MRSE) and gram-negative bacteria (E. coli)†Secure skin closure is an integral step of nearly every surgical procedure. If the closure device does not provide the strength and support required by the skin tissue, the wound edges may separate, providing a potential pathway for bacterial contamination, which can lead to infection, suboptimal cosmesis, and low patient satisfaction.170,171DERMABOND ADVANCED Adhesive can add strength and protection to an incision.•Strength: When used in addition to sutures, DERMABOND ADVANCED Adhesive was shown ex vivo to add 75% more strength to wound closure than sutures alone1•Microbial barrier: DERMABOND ADVANCED Adhesive provides a microbial barrier with 99% protection in vitro for at least 72 hours against organisms commonly responsible for surgical site infections (SSIs)117,192,*•Inhibition of bacteria: DERMABOND ADVANCED Adhesive demonstrated in vitro inhibition of gram-positive bacteria (MRSA & MRSE) and gram-negative bacteria (E. coli)†
